Key result
12-lead mean QT dispersion did not significantly differ between heart transplant recipients who died (61 ms) and those who survived (58 ms, P=0.57), showing no association with mortality or sudden cardiac death.
Why the study?
Does QT dispersion predict mortality and sudden cardiac death in heart transplant recipients?
Cohort (n=346)
Single-blind
No
Does QT dispersion predict mortality and sudden cardiac death in heart transplant recipients?
QT dispersion does not correlate with sudden cardiac death or mortality in heart transplant recipients and should not be used as a prognostic marker.
QT dispersion should not guide prognosis in heart transplant recipients; leaves open whether alternative ECG markers predict outcomes in this population.
BACKGROUND: Sudden cardiac death (SCD) has been shown to be a significant cause of death after heart transplantation. QT dispersion (QTd) is associated with SCD in several high-risk populations. We hypothesized that QTd would predict mortality and SCD in heart transplantation patients. METHODS: We examined the clinical charts and most recent electrocardiograms (ECGs) for patients who received heart transplants at Stanford University Medical Center during the period 1981-1995. QTd was measured with all 12 leads and the precordial leads. Analysis was performed by a single reader blinded to patient outcomes. RESULTS: A total of 346 patients who had undergone transplantation had available ECGs and known outcomes; 155 of these patients died, and 42 of these deaths were attributed to SCD. The 12-lead mean QTd was not significantly different between outcome groups: patients who survived had a 12-lead mean QTd of 58 +/- 29 milliseconds and those who died had a 12-lead mean QTd of 61 +/- 32 milliseconds (P = .57). Patients who died from SCD had a 12-lead mean QTd of 57 +/- 31 milliseconds (P = .40), and those who died of other causes had a 12-lead mean QTd of 59 +/- 34 milliseconds (P = .36 vs those who died of SCD). Similarly, the precordial-lead mean QTd did not differ significantly between the different outcome groups. CONCLUSIONS: We found no correlation between QTd and SCD or mortality in heart transplant recipients. Until additional studies prove a positive association, QTd should not be used as a prognostic marker in these patients.
No takes yet. Share an insight, caveat, or question.
Marcus et al. (2008) conducted a cohort in Heart transplant recipients (n=346). QT dispersion vs. Surviving patients / Patients without sudden cardiac death was evaluated on 12-lead mean QT dispersion in deceased vs surviving patients (p=0.57). 12-lead mean QT dispersion did not significantly differ between heart transplant recipients who died (61 ms) and those who survived (58 ms, P=0.57), showing no association with mortality or sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: